CIPN is commonly associated with taxanes (paclitaxel, docetaxel), platinum agents (cisplatin, carboplatin, oxaliplatin), vinca alkaloids (vincristine), and proteasome inhibitors (bortezomib).

Recovery varies widely. Many patients see improvement over 3–4 months, and some continue to have symptoms for 12 months or longer. Neuromodulation supports this process by helping the brain and peripheral nerves re‑establish more efficient communication patterns.

Yes. Chemotherapy-induced neuropathy (CIPN) often begins in the hands and feet, causing numbness, tingling, burning, or balance changes. It is referred to as a stocking-and-glove syndrome where symptoms commonly occur from the fingertips to elbows and from the toes to the knees. Neuromodulation and sensory‑focused interventions help retrain how the brain interprets these signals, improving comfort and stability.

Some people use cold gloves or socks during infusion if recommended by their oncologist. Reporting symptoms early and using supportive therapies can sometimes lessen how severe they become. Early research from our lab also suggests that starting neurofeedback before chemotherapy may help reduce brain changes linked to neuropathy, but larger studies are still needed.

Many patients regain confidence and stability in walking. Our published research shows that the average reduction in symptoms after neurofeedback is 2.63 points, which is a greater reduction in symptoms than most interventions, including medications.

Yes. Many patients use compression socks, gel‑padded or thermal socks, textured sensory‑stimulating socks, or protective gloves. These can improve comfort, but they work best when paired with therapies that address the underlying nervous‑system changes, such as neuromodulation.

Medications can help reduce pain signals, but they often have side effects and may not fully address sensory changes. Neuromodulation focuses on: Improving sensory processing Reducing hypersensitivity Supporting neuroplasticity Calming overactive pain pathways Many patients use neuromodulation alongside their medical care to improve comfort and function.

Conventional oncology focuses on treating the cancer itself. Integrative oncology adds evidence‑supported therapies that address: Pain Fatigue Anxiety Sleep Cognitive changes Quality of life Neuromodulation fits naturally within integrative oncology because it is non‑pharmacologic, data‑driven, and supportive of whole‑person recovery.